OncoCyte Corp. | Ownership
Companies that own OncoCyte Corp.
Broadwood Capital, Inc.
7,564,934
18.6%
0
1.85%
06/30/2018
The Vanguard Group, Inc.
389,897
0.96%
40,100
0%
06/30/2018
Bridgeway Capital Management, Inc.
300,000
0.74%
185,000
0.01%
06/30/2018
Invus Public Equities Advisors LLC
150,000
0.37%
0
0.01%
06/30/2018
Millennium Management LLC
123,812
0.3%
123,812
0%
06/30/2018
BlackRock Fund Advisors
66,146
0.16%
-134,389
0%
06/30/2018
Element Capital Management LLC
58,517
0.14%
58,517
0%
06/30/2018
British & American Investment Trust Plc (Invt Mgmt)
30,545
0.08%
-11,671
0.25%
12/31/2017
Goldman Sachs & Co. LLC (Private Banking)
18,466
0.05%
-10,751
0%
06/30/2018
Geode Capital Management LLC
15,544
0.04%
-8,311
0%
06/30/2018
| Address |
1010 Atlantic Avenue
Alameda California 94501
United States
|
|
Employees
|
- |
| Website |
http://www.oncocyte.com |
| Updated |
07/08/2019 |
| OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA. |
